
Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

